ClinicalTrials.gg

Drug

Albumin-Bound Paclitaxel clinical trials

Also written Abraxane and ABI-007.

A product of Paclitaxel; its studies count on that page too.

studies test it
674
open now
177
in phase 3
51
first study started
1999

Keep track of what changes. Save the Albumin-Bound Paclitaxel studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

673 studies that test it; most in 2019 (48); 1 more planned to start later

Studies that test Albumin-Bound Paclitaxel, by start year
YearStudies
19991
20001
20012
20033
20043
200510
200619
200717
200827
200910
201013
201113
201221
201330
201441
201535
201631
201733
201831
201948
202048
202141
202247
202339
202436
202538
202635

By phase

A phase 1/2 study counts in both.

Early Phase 1
7
Phase 1
202
Phase 2
499
Phase 3
51
Phase 4
9
No phase
16

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 134 · Other 540

Fudan University (27) · Celgene (26) · ImmunityBio, Inc. (21) · M.D. Anderson Cancer Center (17) · Sun Yat-sen University (12) · Tianjin Medical University Cancer Institute and Hospital (11) · Chinese PLA General Hospital (11) · City of Hope Medical Center (9)

Often tested with

Tested in the same studies.

Gemcitabine (197) · Carboplatin (94) · Cisplatin (78) · Bevacizumab (50) · Cyclophosphamide (37) · Capecitabine (35) · Fluorouracil (33) · Leucovorin (27)

Studies

Open first, then newest update. How each study uses Albumin-Bound Paclitaxel is read from its arms, and is right about nine times in ten.

Testing it · 674

See all 674 studies that test Albumin-Bound Paclitaxel →

Given in every arm · 412 — Albumin-Bound Paclitaxel is usual care beside what is tested

Showing 20 of 412.

As the comparator · 52 — what is tested is compared with Albumin-Bound Paclitaxel

Showing 20 of 52.